ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Myasthenia Gravis (MG) Treatment Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-11L13917
Home | Market Reports | Health| Health Foundations & Medical Research
Global Myasthenia Gravis MG Treatment Market Research Report 2023
BUY CHAPTERS

Global Myasthenia Gravis (MG) Treatment Market Research Report 2025

Code: QYRE-Auto-11L13917
Report
September 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alexion Pharmaceutical
Grifols S A
Avadel Pharmaceuticals
Novartis
Pfizer Inc
AbbVie
F.Hoffmann-La Roche
GlaxoSmithKline PLC
Bausch Health Companies
Shire Plc

Myasthenia Gravis (MG) Treatment Market Size

The global market for Myasthenia Gravis (MG) Treatment was valued at US$ 1551 million in the year 2024 and is projected to reach a revised size of US$ 2246 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Myasthenia Gravis (MG) Treatment Market

Myasthenia Gravis (MG) Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Myasthenia Gravis (MG) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myasthenia Gravis (MG) Treatment.
The Myasthenia Gravis (MG) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myasthenia Gravis (MG) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myasthenia Gravis (MG) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Myasthenia Gravis (MG) Treatment Market Report

Report Metric Details
Report Name Myasthenia Gravis (MG) Treatment Market
Accounted market size in year US$ 1551 million
Forecasted market size in 2031 US$ 2246 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Drug Treatment
  • Rapid Immunotherapies
  • Others
Segment by Application
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic and Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alexion Pharmaceutical, Grifols, Avadel Pharmaceuticals, Novartis, Pfizer, AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, Bausch Health Companies, Shire
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Myasthenia Gravis (MG) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Myasthenia Gravis (MG) Treatment Market growing?

Ans: The Myasthenia Gravis (MG) Treatment Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Myasthenia Gravis (MG) Treatment Market size in 2031?

Ans: The Myasthenia Gravis (MG) Treatment Market size in 2031 will be US$ 2246 million.

Who are the main players in the Myasthenia Gravis (MG) Treatment Market report?

Ans: The main players in the Myasthenia Gravis (MG) Treatment Market are Alexion Pharmaceutical, Grifols, Avadel Pharmaceuticals, Novartis, Pfizer, AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, Bausch Health Companies, Shire

What are the Application segmentation covered in the Myasthenia Gravis (MG) Treatment Market report?

Ans: The Applications covered in the Myasthenia Gravis (MG) Treatment Market report are Hospitals and Clinics, Diagnostic Centers, Academic and Research Organizations

What are the Type segmentation covered in the Myasthenia Gravis (MG) Treatment Market report?

Ans: The Types covered in the Myasthenia Gravis (MG) Treatment Market report are Drug Treatment, Rapid Immunotherapies, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Treatment
1.2.3 Rapid Immunotherapies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myasthenia Gravis (MG) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis (MG) Treatment Market Perspective (2020-2031)
2.2 Global Myasthenia Gravis (MG) Treatment Growth Trends by Region
2.2.1 Global Myasthenia Gravis (MG) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Myasthenia Gravis (MG) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Myasthenia Gravis (MG) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Myasthenia Gravis (MG) Treatment Market Dynamics
2.3.1 Myasthenia Gravis (MG) Treatment Industry Trends
2.3.2 Myasthenia Gravis (MG) Treatment Market Drivers
2.3.3 Myasthenia Gravis (MG) Treatment Market Challenges
2.3.4 Myasthenia Gravis (MG) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue
3.1.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue (2020-2025)
3.1.2 Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Myasthenia Gravis (MG) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Myasthenia Gravis (MG) Treatment Revenue
3.4 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis (MG) Treatment Revenue in 2024
3.5 Global Key Players of Myasthenia Gravis (MG) Treatment Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis (MG) Treatment, Product and Application
3.7 Global Key Players of Myasthenia Gravis (MG) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis (MG) Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2026-2031)
5 Myasthenia Gravis (MG) Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
6.2 North America Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
6.4 North America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
7.2 Europe Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
7.4 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
9.2 Latin America Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
9.4 Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceutical
11.1.1 Alexion Pharmaceutical Company Details
11.1.2 Alexion Pharmaceutical Business Overview
11.1.3 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Introduction
11.1.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.1.5 Alexion Pharmaceutical Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Myasthenia Gravis (MG) Treatment Introduction
11.2.4 Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Avadel Pharmaceuticals
11.3.1 Avadel Pharmaceuticals Company Details
11.3.2 Avadel Pharmaceuticals Business Overview
11.3.3 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Introduction
11.3.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.3.5 Avadel Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Myasthenia Gravis (MG) Treatment Introduction
11.4.4 Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Myasthenia Gravis (MG) Treatment Introduction
11.5.4 Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Myasthenia Gravis (MG) Treatment Introduction
11.6.4 AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Details
11.9.2 Bausch Health Companies Business Overview
11.9.3 Bausch Health Companies Myasthenia Gravis (MG) Treatment Introduction
11.9.4 Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.9.5 Bausch Health Companies Recent Development
11.10 Shire
11.10.1 Shire Company Details
11.10.2 Shire Business Overview
11.10.3 Shire Myasthenia Gravis (MG) Treatment Introduction
11.10.4 Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.10.5 Shire Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Alexion Pharmaceutical
Grifols S A
Avadel Pharmaceuticals
Novartis
Pfizer Inc
AbbVie
F.Hoffmann-La Roche
GlaxoSmithKline PLC
Bausch Health Companies
Shire Plc
List of Tables
 Table 1. Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug Treatment
 Table 3. Key Players of Rapid Immunotherapies
 Table 4. Key Players of Others
 Table 5. Global Myasthenia Gravis (MG) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Myasthenia Gravis (MG) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Myasthenia Gravis (MG) Treatment Market Share by Region (2020-2025)
 Table 9. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Myasthenia Gravis (MG) Treatment Market Share by Region (2026-2031)
 Table 11. Myasthenia Gravis (MG) Treatment Market Trends
 Table 12. Myasthenia Gravis (MG) Treatment Market Drivers
 Table 13. Myasthenia Gravis (MG) Treatment Market Challenges
 Table 14. Myasthenia Gravis (MG) Treatment Market Restraints
 Table 15. Global Myasthenia Gravis (MG) Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Myasthenia Gravis (MG) Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2024)
 Table 18. Ranking of Global Top Myasthenia Gravis (MG) Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis (MG) Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Myasthenia Gravis (MG) Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Myasthenia Gravis (MG) Treatment, Product and Application
 Table 22. Global Key Players of Myasthenia Gravis (MG) Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Alexion Pharmaceutical Company Details
 Table 48. Alexion Pharmaceutical Business Overview
 Table 49. Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Product
 Table 50. Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 51. Alexion Pharmaceutical Recent Development
 Table 52. Grifols Company Details
 Table 53. Grifols Business Overview
 Table 54. Grifols Myasthenia Gravis (MG) Treatment Product
 Table 55. Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 56. Grifols Recent Development
 Table 57. Avadel Pharmaceuticals Company Details
 Table 58. Avadel Pharmaceuticals Business Overview
 Table 59. Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Product
 Table 60. Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 61. Avadel Pharmaceuticals Recent Development
 Table 62. Novartis Company Details
 Table 63. Novartis Business Overview
 Table 64. Novartis Myasthenia Gravis (MG) Treatment Product
 Table 65. Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 66. Novartis Recent Development
 Table 67. Pfizer Company Details
 Table 68. Pfizer Business Overview
 Table 69. Pfizer Myasthenia Gravis (MG) Treatment Product
 Table 70. Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 71. Pfizer Recent Development
 Table 72. AbbVie Company Details
 Table 73. AbbVie Business Overview
 Table 74. AbbVie Myasthenia Gravis (MG) Treatment Product
 Table 75. AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 76. AbbVie Recent Development
 Table 77. F. Hoffmann-La Roche Company Details
 Table 78. F. Hoffmann-La Roche Business Overview
 Table 79. F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Product
 Table 80. F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 81. F. Hoffmann-La Roche Recent Development
 Table 82. GlaxoSmithKline Company Details
 Table 83. GlaxoSmithKline Business Overview
 Table 84. GlaxoSmithKline Myasthenia Gravis (MG) Treatment Product
 Table 85. GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 86. GlaxoSmithKline Recent Development
 Table 87. Bausch Health Companies Company Details
 Table 88. Bausch Health Companies Business Overview
 Table 89. Bausch Health Companies Myasthenia Gravis (MG) Treatment Product
 Table 90. Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 91. Bausch Health Companies Recent Development
 Table 92. Shire Company Details
 Table 93. Shire Business Overview
 Table 94. Shire Myasthenia Gravis (MG) Treatment Product
 Table 95. Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
 Table 96. Shire Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Myasthenia Gravis (MG) Treatment Picture
 Figure 2. Global Myasthenia Gravis (MG) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Myasthenia Gravis (MG) Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Drug Treatment Features
 Figure 5. Rapid Immunotherapies Features
 Figure 6. Others Features
 Figure 7. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals and Clinics Case Studies
 Figure 10. Diagnostic Centers Case Studies
 Figure 11. Academic and Research Organizations Case Studies
 Figure 12. Myasthenia Gravis (MG) Treatment Report Years Considered
 Figure 13. Global Myasthenia Gravis (MG) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Myasthenia Gravis (MG) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Myasthenia Gravis (MG) Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Myasthenia Gravis (MG) Treatment Market Share by Players in 2024
 Figure 17. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Myasthenia Gravis (MG) Treatment Revenue in 2024
 Figure 19. North America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
 Figure 21. United States Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Share by Region (2020-2031)
 Figure 33. China Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 49. Grifols Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 50. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 53. AbbVie Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 55. GlaxoSmithKline Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 56. Bausch Health Companies Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 57. Shire Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Myasthenia Gravis Drugs Market Research Report 2025
Global Autoimmune Diseases Treatment Market Research Report 2024
Global Medicines for Alzheimer Disease Treatment Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global Ant Killer Market Research Report 2024
Global Treatment Planning Software Market Research Report 2025
Global Early Diagnosis Kit For Alzheimer s Disease Market Research Report 2024
Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024
Global Intramuscular Drug Delivery Market
Global Tauopathies Treatment Market Research Report 2025
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Global Immune Drugs Market Insights Forecast to 2030
Global Angina Pectoris Treatment Market Research Report 2024
Global Combination Therapy Drug Market Research Report 2025
Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Treatment Market Research Report 2024
Global Pharma Contract Service Market Research Report 2025
Global Pharmaceutical Validation Services Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024

RELATED REPORTS

Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H13194
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P9123
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Othe-477
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9W6217
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions